MedPath

The effect of melatonin on cognitive function, after coronary artery bypass grafting surgery.

Phase 2
Conditions
Coronary Artery Bypass Grafting Surgery..
Atherosclerotic heart disease of native coronary artery
I25.1
Registration Number
IRCT20141009019470N77
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients aged 40-75 years
Patients who are undergoing elective Cardio pulmonary artery bypass grafting.

Exclusion Criteria

Acute recent Myocardial Infarction (less than 3 month)
Aortic atheromatosis
Renal dysfunction;
Peripheral vascular disease;
Pump time more than 90 min;
Corticosteroid therapy since 1 month ago;
infection less than 4 weeks ago;
Breast feeding
Pregnancy;
Dementia;
Psychiatric disorders
Using Benzodiazepines and opioid;
Alcohol abuse
Hepatic insufficiency
Non sinus ECG;
Concomitant cardiac surgery;
Anticoagulation therapy with warfarin
ASA higher than 3
Ejection Fraction less than 45%
Severe pulmonary disease
Cerebrovascular disease
Immunologic disorders
Re-operation
Emergency operation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive function. Timepoint: 4 weeks before surgery,2 days after surgery and 6 weeks after melatonin administration. Method of measurement: Cognitive function Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath